SALIX PHARMACEUTICALS LTD Files SEC form 8-K, Change in Directors or Principal Officers,...

| Request a Trial to NEW EDGAR Online Pro Form 8-K for SALIX PHARMACEUTICALS LTD Change in Directors or Principal Officers, Financial Statements and Exh Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On June 12, 2008, upon the recommendation of the Compensation Committee and upon consideration of data provided by peer review results, the Board of Directors of Salix approved revision of the severance benefits provided in the Employment Agreements with each of its corporate officers to include payment of such severance benefits in the event of a change of control and, if the officer's employment with Salix is terminated by the company other than "for cause," or if the officer terminates employment with Salix for "good... [read full story]